SPL 9.20% 9.5¢ starpharma holdings limited

"Starpharma is now in a particularly strong position to expedite...

  1. 4,843 Posts.
    lightbulb Created with Sketch. 250
    "Starpharma is now in a particularly strong position to expedite and expand the development of internal DEP® candidates and broaden our pipeline to run more DEP® clinical trials in parallel, while continuing to commercialise the VivaGel® portfolio.” “The remainder of 2017 represents a particularly exciting period for Starpharma"

    The CEO is really starting to talk like a full blown Pharma rather than a little Biotech, Yes we have an oncology pipeline pretty damn exciting imo.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.008(9.20%)
Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.